Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 3
2005 2
2007 1
2008 6
2009 3
2010 7
2011 6
2012 2
2013 6
2014 1
2015 13
2016 5
2017 7
2018 14
2019 16
2020 12
2021 14
2022 17
2023 17
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases.
Kobayashi S, Bando H, Taketomi A, Takamoto T, Shinozaki E, Shiozawa M, Hara H, Yamazaki K, Komori K, Matsuhashi N, Kato T, Kagawa Y, Yokota M, Oki E, Komine K, Takahashi S, Wakabayashi M, Yoshino T. Kobayashi S, et al. Among authors: shinozaki e. BMC Cancer. 2023 Aug 21;23(1):779. doi: 10.1186/s12885-023-11311-5. BMC Cancer. 2023. PMID: 37605122 Free PMC article. Clinical Trial.
Immunotherapy in Colorectal Cancer: Current and Future Strategies.
Ooki A, Shinozaki E, Yamaguchi K. Ooki A, et al. Among authors: shinozaki e. J Anus Rectum Colon. 2021 Jan 28;5(1):11-24. doi: 10.23922/jarc.2020-064. eCollection 2021. J Anus Rectum Colon. 2021. PMID: 33537496 Free PMC article. Review.
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
Dankner M, Wang Y, Fazelzad R, Johnson B, Nebhan CA, Dagogo-Jack I, Myall NJ, Richtig G, Bracht JWP, Gerlinger M, Shinozaki E, Yoshino T, Kotani D, Fangusaro JR, Gautschi O, Mazieres J, Sosman JA, Kopetz S, Subbiah V, Davies MA, Groover AL, Sullivan RJ, Flaherty KT, Johnson DB, Benedetti A, Cescon DW, Spreafico A, Zogopoulos G, Rose AAN. Dankner M, et al. Among authors: shinozaki e. JCO Precis Oncol. 2022 Aug;6:e2200107. doi: 10.1200/PO.22.00107. JCO Precis Oncol. 2022. PMID: 35977349 Free PMC article.
Clinical utility of circulating tumor DNA for colorectal cancer.
Osumi H, Shinozaki E, Yamaguchi K, Zembutsu H. Osumi H, et al. Among authors: shinozaki e. Cancer Sci. 2019 Apr;110(4):1148-1155. doi: 10.1111/cas.13972. Epub 2019 Mar 4. Cancer Sci. 2019. PMID: 30742729 Free PMC article. Review.
Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer.
Bando H, Nakamura Y, Taniguchi H, Shiozawa M, Yasui H, Esaki T, Kagawa Y, Denda T, Satoh T, Yamazaki K, Sunakawa Y, Kato T, Goto M, Yuki S, Nishina T, Oki E, Shinozaki E, Matsuhashi N, Takahashi N, Tsuji A, Ohtsubo K, Wakabayashi M, Ikeno T, Hata M, Odegaard JI, Yoshino T. Bando H, et al. Among authors: shinozaki e. JCO Precis Oncol. 2022 Apr;6:e2100535. doi: 10.1200/PO.21.00535. JCO Precis Oncol. 2022. PMID: 35544728
Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial).
Akiyoshi T, Shinozaki E, Taguchi S, Chino A, Hiratsuka M, Tominaga T, Nonaka T, Toda S, Matoba S, Matsui S, Okabayashi K, Mukai T, Hiyoshi Y, Yamaguchi T, Nagasaki T, Yamaguchi K, Ueno M, Kuroyanagi H, Fukunaga Y, Ishizuka N, Konishi T; for NOMINATE Collaborative Group. Akiyoshi T, et al. Among authors: shinozaki e. BMJ Open. 2022 Mar 18;12(3):e055140. doi: 10.1136/bmjopen-2021-055140. BMJ Open. 2022. PMID: 35304396 Free PMC article. Clinical Trial.
A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer.
Osumi H, Takashima A, Ooki A, Yoshinari Y, Wakatsuki T, Hirano H, Nakayama I, Okita N, Sawada R, Ouchi K, Fukuda K, Fukuoka S, Ogura M, Takahari D, Chin K, Shoji H, Kato K, Ishizuka N, Boku N, Yamaguchi K, Shinozaki E. Osumi H, et al. Among authors: shinozaki e. Transl Oncol. 2023 Sep;35:101718. doi: 10.1016/j.tranon.2023.101718. Epub 2023 Jun 24. Transl Oncol. 2023. PMID: 37364334 Free PMC article.
139 results